

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrion distribution (GO:0048311) | 5.69956125 |
| 2 | NIK/NF-kappaB signaling (GO:0038061) | 5.56915300 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.42366770 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.42366770 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.42366770 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.42366770 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.42366770 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 5.42366770 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.31175609 |
| 10 | regulation of penile erection (GO:0060405) | 5.21816200 |
| 11 | response to peptidoglycan (GO:0032494) | 5.00748675 |
| 12 | response to muramyl dipeptide (GO:0032495) | 4.99208981 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.97191697 |
| 14 | positive regulation of heat generation (GO:0031652) | 4.77706128 |
| 15 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.69613360 |
| 16 | nerve growth factor signaling pathway (GO:0038180) | 4.69164804 |
| 17 | regulation of fever generation (GO:0031620) | 4.54840808 |
| 18 | specification of organ identity (GO:0010092) | 4.53364884 |
| 19 | granulocyte activation (GO:0036230) | 4.45188491 |
| 20 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.44275105 |
| 21 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.41860460 |
| 22 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.39130375 |
| 23 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.38773411 |
| 24 | prenylation (GO:0097354) | 4.35175173 |
| 25 | protein prenylation (GO:0018342) | 4.35175173 |
| 26 | regulation of NFAT protein import into nucleus (GO:0051532) | 4.35020481 |
| 27 | neutrophil activation (GO:0042119) | 4.31737689 |
| 28 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.15266743 |
| 29 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.14320174 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 4.11409555 |
| 31 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.10190578 |
| 32 | natural killer cell mediated immunity (GO:0002228) | 4.10190578 |
| 33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.07956781 |
| 34 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.02117115 |
| 35 | superoxide anion generation (GO:0042554) | 3.93267214 |
| 36 | positive regulation of interleukin-12 production (GO:0032735) | 3.88212748 |
| 37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.87513026 |
| 38 | positive regulation of developmental pigmentation (GO:0048087) | 3.75258957 |
| 39 | positive regulation of humoral immune response (GO:0002922) | 3.71205978 |
| 40 | regulation of pigment cell differentiation (GO:0050932) | 3.68417252 |
| 41 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.65245077 |
| 42 | hindbrain development (GO:0030902) | 3.65159230 |
| 43 | regulation of chemokine biosynthetic process (GO:0045073) | 3.58935488 |
| 44 | reactive oxygen species biosynthetic process (GO:1903409) | 3.58868087 |
| 45 | regulation of heat generation (GO:0031650) | 3.57354827 |
| 46 | regulation of mononuclear cell migration (GO:0071675) | 3.57349285 |
| 47 | positive regulation of interferon-alpha production (GO:0032727) | 3.57026143 |
| 48 | cytokine secretion (GO:0050663) | 3.54250545 |
| 49 | positive regulation of antigen processing and presentation (GO:0002579) | 3.52273487 |
| 50 | myeloid dendritic cell differentiation (GO:0043011) | 3.51148746 |
| 51 | respiratory burst (GO:0045730) | 3.50174276 |
| 52 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.48281345 |
| 53 | response to host immune response (GO:0052572) | 3.48281345 |
| 54 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.42476393 |
| 55 | response to nerve growth factor (GO:1990089) | 3.42476393 |
| 56 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.42471463 |
| 57 | regulation of interferon-alpha production (GO:0032647) | 3.40353978 |
| 58 | short-term memory (GO:0007614) | 3.40120669 |
| 59 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.38663020 |
| 60 | regulation of RIG-I signaling pathway (GO:0039535) | 3.36896842 |
| 61 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.36840104 |
| 62 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.36739567 |
| 63 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.35918805 |
| 64 | neutrophil mediated immunity (GO:0002446) | 3.31642420 |
| 65 | detection of molecule of bacterial origin (GO:0032490) | 3.31249976 |
| 66 | negative regulation of lipid storage (GO:0010888) | 3.31248533 |
| 67 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.30660916 |
| 68 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.29649267 |
| 69 | mitochondrion localization (GO:0051646) | 3.28902358 |
| 70 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.23063933 |
| 71 | microglial cell activation (GO:0001774) | 3.22344870 |
| 72 | myeloid dendritic cell activation (GO:0001773) | 3.22280530 |
| 73 | T cell lineage commitment (GO:0002360) | 3.21691156 |
| 74 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.21058291 |
| 75 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.20238109 |
| 76 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.18790910 |
| 77 | regulation of interleukin-12 production (GO:0032655) | 3.18147150 |
| 78 | behavioral response to ethanol (GO:0048149) | 3.17484224 |
| 79 | regulation of chronic inflammatory response (GO:0002676) | 3.15034274 |
| 80 | leukocyte mediated cytotoxicity (GO:0001909) | 3.14266222 |
| 81 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.12918838 |
| 82 | regulation of immunoglobulin secretion (GO:0051023) | 3.11727112 |
| 83 | response to host (GO:0075136) | 3.08788796 |
| 84 | response to host defenses (GO:0052200) | 3.08788796 |
| 85 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.08788796 |
| 86 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.06859631 |
| 87 | positive regulation of interferon-beta production (GO:0032728) | 3.06698186 |
| 88 | macrophage activation (GO:0042116) | 3.06687233 |
| 89 | myeloid cell activation involved in immune response (GO:0002275) | 3.04380464 |
| 90 | positive regulation of p38MAPK cascade (GO:1900745) | 3.04349036 |
| 91 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.04332845 |
| 92 | response to lipoprotein particle (GO:0055094) | 3.04184209 |
| 93 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.03671987 |
| 94 | I-kappaB phosphorylation (GO:0007252) | 3.01664543 |
| 95 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.00925721 |
| 96 | negative regulation of interleukin-12 production (GO:0032695) | 2.98992526 |
| 97 | Rap protein signal transduction (GO:0032486) | 2.97368868 |
| 98 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.97197654 |
| 99 | positive regulation of T cell cytokine production (GO:0002726) | 2.96523790 |
| 100 | monocyte chemotaxis (GO:0002548) | 2.96019076 |
| 101 | regulation of antigen processing and presentation (GO:0002577) | 2.94140887 |
| 102 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.93836623 |
| 103 | T-helper cell differentiation (GO:0042093) | 2.92035180 |
| 104 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.92035180 |
| 105 | positive regulation of vasculogenesis (GO:2001214) | 2.90663884 |
| 106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90632940 |
| 107 | cell adhesion mediated by integrin (GO:0033627) | 2.89482612 |
| 108 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.87756989 |
| 109 | negative regulation of interleukin-17 production (GO:0032700) | 2.87001881 |
| 110 | cellular response to zinc ion (GO:0071294) | 2.86434731 |
| 111 | regulation of interleukin-1 secretion (GO:0050704) | 2.86394164 |
| 112 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.86244833 |
| 113 | positive regulation of type 2 immune response (GO:0002830) | 2.86023028 |
| 114 | regulation of monocyte differentiation (GO:0045655) | 2.85877744 |
| 115 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.85640039 |
| 116 | activation of MAPKKK activity (GO:0000185) | 2.83957264 |
| 117 | germinal center formation (GO:0002467) | 2.82433362 |
| 118 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.82198807 |
| 119 | regulation of integrin activation (GO:0033623) | 2.82071001 |
| 120 | immunoglobulin mediated immune response (GO:0016064) | 2.81376109 |
| 121 | dendritic cell differentiation (GO:0097028) | 2.79550016 |
| 122 | positive regulation of chemokine production (GO:0032722) | 2.79505653 |
| 123 | positive regulation of acute inflammatory response (GO:0002675) | 2.78261321 |
| 124 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.77431497 |
| 125 | myeloid leukocyte mediated immunity (GO:0002444) | 2.76492792 |
| 126 | regulation of vitamin metabolic process (GO:0030656) | 2.76056997 |
| 127 | positive regulation of RNA splicing (GO:0033120) | 2.75984513 |
| 128 | T-helper 1 type immune response (GO:0042088) | 2.74482749 |
| 129 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.73856999 |
| 130 | positive regulation of interleukin-6 production (GO:0032755) | 2.72973816 |
| 131 | eosinophil chemotaxis (GO:0048245) | 2.72052970 |
| 132 | myeloid leukocyte activation (GO:0002274) | 2.71278202 |
| 133 | histone H3-K4 trimethylation (GO:0080182) | 2.71123395 |
| 134 | cellular response to arsenic-containing substance (GO:0071243) | 2.69547989 |
| 135 | chemosensory behavior (GO:0007635) | 2.66076693 |
| 136 | positive regulation of macrophage cytokine production (GO:0060907) | 2.65496676 |
| 137 | positive regulation of cell size (GO:0045793) | 2.65427840 |
| 138 | fibroblast migration (GO:0010761) | 2.64471562 |
| 139 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.63627747 |
| 140 | cellular response to nicotine (GO:0071316) | 2.63553129 |
| 141 | regulation of alkaline phosphatase activity (GO:0010692) | 2.58653222 |
| 142 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.58327963 |
| 143 | regulation of vascular permeability (GO:0043114) | 2.56633621 |
| 144 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.50723148 |
| 145 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.47368402 |
| 146 | establishment of endothelial barrier (GO:0061028) | 2.45563498 |
| 147 | cellular response to ethanol (GO:0071361) | 2.45075495 |
| 148 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 2.43720356 |
| 149 | negative regulation of necrotic cell death (GO:0060547) | 2.43558459 |
| 150 | response to histamine (GO:0034776) | 2.42644505 |
| 151 | positive regulation of interleukin-2 production (GO:0032743) | 2.42157272 |
| 152 | sphingosine metabolic process (GO:0006670) | 2.41591921 |
| 153 | negative regulation of neurotransmitter transport (GO:0051589) | 2.41528593 |
| 154 | cellular response to lipopolysaccharide (GO:0071222) | 2.41383807 |
| 155 | positive regulation of neurotransmitter transport (GO:0051590) | 2.40887458 |
| 156 | regulation of macrophage cytokine production (GO:0010935) | 2.40857785 |
| 157 | response to inactivity (GO:0014854) | 2.34928842 |
| 158 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.34695881 |
| 159 | vesicle transport along microtubule (GO:0047496) | 2.34629311 |
| 160 | icosanoid secretion (GO:0032309) | 2.34343572 |
| 161 | arachidonic acid secretion (GO:0050482) | 2.34343572 |
| 162 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.33267780 |
| 163 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.32094925 |
| 164 | cellular response to molecule of bacterial origin (GO:0071219) | 2.32019002 |
| 165 | regulation of protein polyubiquitination (GO:1902914) | 2.30637510 |
| 166 | regulation of podosome assembly (GO:0071801) | 2.28743611 |
| 167 | ganglion development (GO:0061548) | 2.26230679 |
| 168 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 2.26155283 |
| 169 | regulation of T-helper cell differentiation (GO:0045622) | 2.25850879 |
| 170 | regulation of DNA-templated transcription, initiation (GO:2000142) | 2.24107976 |
| 171 | cellular response to type I interferon (GO:0071357) | 2.24021974 |
| 172 | type I interferon signaling pathway (GO:0060337) | 2.24021974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.40444142 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.10857569 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.82338062 |
| 4 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.83631214 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.76743953 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.75069842 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.72383115 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.69417382 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.50844468 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.47558381 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.32002556 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.29515158 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.12903709 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.08173886 |
| 15 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.82654679 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.65734604 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.52825891 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38471639 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.32919628 |
| 20 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.26263275 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19601375 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.90462728 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87219282 |
| 24 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.83701103 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.81416321 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80952279 |
| 27 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.79970824 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.77238324 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.70358499 |
| 30 | TP53_16413492_ChIP-PET_HCT116_Human | 1.69545128 |
| 31 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.67508610 |
| 32 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55765364 |
| 33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.54051119 |
| 34 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51703981 |
| 35 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.50836799 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.50621989 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.46839730 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46189382 |
| 39 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.46181276 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43631082 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.41516971 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41044811 |
| 43 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.40236323 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.38624321 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.38292872 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38253692 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36202821 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35465610 |
| 49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35129172 |
| 50 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.34233097 |
| 51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.31886015 |
| 52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28737733 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28737733 |
| 54 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.26213623 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26059929 |
| 56 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25272235 |
| 57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.22652605 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.21094708 |
| 59 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.20217077 |
| 60 | MYB_26560356_Chip-Seq_TH2_Human | 1.19364885 |
| 61 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.17442341 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17439292 |
| 63 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17323676 |
| 64 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16784594 |
| 65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.15358423 |
| 66 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.13063004 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12085422 |
| 68 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.11869273 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11546131 |
| 70 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10018898 |
| 71 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.09754158 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09669986 |
| 73 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09568863 |
| 74 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.09414864 |
| 75 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.08520180 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07189354 |
| 77 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07065619 |
| 78 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06317976 |
| 79 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05932629 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05409526 |
| 81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05318724 |
| 82 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03540190 |
| 83 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03180803 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02703185 |
| 85 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01220485 |
| 86 | MYB_26560356_Chip-Seq_TH1_Human | 1.00957986 |
| 87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.00951246 |
| 88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00522333 |
| 89 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97379076 |
| 90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94585895 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94438335 |
| 92 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93180470 |
| 93 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.93132923 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92759267 |
| 95 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92731665 |
| 96 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92712254 |
| 97 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92712254 |
| 98 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92697151 |
| 99 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91898283 |
| 100 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91769515 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90768363 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90734163 |
| 103 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89737487 |
| 104 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89692131 |
| 105 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89062414 |
| 106 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88860668 |
| 107 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88523972 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88413591 |
| 109 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88149243 |
| 110 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87479708 |
| 111 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86798660 |
| 112 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.86242848 |
| 113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85963886 |
| 114 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.85717674 |
| 115 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.84675248 |
| 116 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.83639943 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83033490 |
| 118 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.82307165 |
| 119 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.81788175 |
| 120 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.80865232 |
| 121 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.79796826 |
| 122 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.79761873 |
| 123 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.78836680 |
| 124 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.78656992 |
| 125 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.78382244 |
| 126 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78233180 |
| 127 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.76676763 |
| 128 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76499114 |
| 129 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.76260003 |
| 130 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.75708411 |
| 131 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75448782 |
| 132 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.74612824 |
| 133 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74224908 |
| 134 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73491756 |
| 135 | MAF_26560356_Chip-Seq_TH1_Human | 0.73022325 |
| 136 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72649147 |
| 137 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.72600666 |
| 138 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.72314472 |
| 139 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70949974 |
| 140 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.70523154 |
| 141 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69661854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.68082742 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.48060929 |
| 3 | MP0003436_decreased_susceptibility_to | 3.63067865 |
| 4 | MP0004510_myositis | 3.52184594 |
| 5 | MP0009785_altered_susceptibility_to | 3.48870561 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.38135972 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.22947983 |
| 8 | MP0002254_reproductive_system_inflammat | 3.21295153 |
| 9 | MP0002419_abnormal_innate_immunity | 2.98109497 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.97668211 |
| 11 | MP0003303_peritoneal_inflammation | 2.93454858 |
| 12 | MP0000685_abnormal_immune_system | 2.79916675 |
| 13 | MP0001790_abnormal_immune_system | 2.77933557 |
| 14 | MP0005387_immune_system_phenotype | 2.77933557 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.55856406 |
| 16 | MP0005025_abnormal_response_to | 2.53372363 |
| 17 | MP0001800_abnormal_humoral_immune | 2.42210877 |
| 18 | MP0002723_abnormal_immune_serum | 2.36235317 |
| 19 | MP0002006_tumorigenesis | 2.25838409 |
| 20 | MP0006082_CNS_inflammation | 2.25756489 |
| 21 | MP0002277_abnormal_respiratory_mucosa | 2.25744312 |
| 22 | MP0003724_increased_susceptibility_to | 2.23393677 |
| 23 | MP0004947_skin_inflammation | 2.22960801 |
| 24 | MP0005671_abnormal_response_to | 2.21910758 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 2.20432208 |
| 26 | MP0001819_abnormal_immune_cell | 2.05813751 |
| 27 | MP0005310_abnormal_salivary_gland | 2.04017853 |
| 28 | MP0002420_abnormal_adaptive_immunity | 2.01367291 |
| 29 | MP0009278_abnormal_bone_marrow | 2.00049487 |
| 30 | MP0002928_abnormal_bile_duct | 1.95899744 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.95782207 |
| 32 | MP0005623_abnormal_meninges_morphology | 1.89545320 |
| 33 | MP0009764_decreased_sensitivity_to | 1.85175528 |
| 34 | MP0005423_abnormal_somatic_nervous | 1.83761115 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.76535468 |
| 36 | MP0005076_abnormal_cell_differentiation | 1.73844123 |
| 37 | MP0005248_abnormal_Harderian_gland | 1.71434328 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.68595458 |
| 39 | MP0000462_abnormal_digestive_system | 1.67987144 |
| 40 | MP0009840_abnormal_foam_cell | 1.67301971 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.64287820 |
| 42 | MP0003448_altered_tumor_morphology | 1.62755314 |
| 43 | MP0000371_diluted_coat_color | 1.59928311 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.58390537 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.57580507 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.56797625 |
| 47 | MP0003252_abnormal_bile_duct | 1.53849100 |
| 48 | MP0010678_abnormal_skin_adnexa | 1.53068156 |
| 49 | MP0003950_abnormal_plasma_membrane | 1.52349611 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.52347398 |
| 51 | MP0001853_heart_inflammation | 1.52291645 |
| 52 | MP0002405_respiratory_system_inflammati | 1.52076413 |
| 53 | MP0000383_abnormal_hair_follicle | 1.48601086 |
| 54 | MP0002163_abnormal_gland_morphology | 1.46791579 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.44558967 |
| 56 | MP0000716_abnormal_immune_system | 1.41476589 |
| 57 | MP0008260_abnormal_autophagy | 1.40128342 |
| 58 | MP0005174_abnormal_tail_pigmentation | 1.36487178 |
| 59 | MP0000013_abnormal_adipose_tissue | 1.35244783 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.34786206 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.34786206 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.34285872 |
| 63 | MP0001299_abnormal_eye_distance/ | 1.32612909 |
| 64 | MP0000778_abnormal_nervous_system | 1.32565820 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 1.31288819 |
| 66 | MP0008004_abnormal_stomach_pH | 1.29245693 |
| 67 | MP0008469_abnormal_protein_level | 1.29082939 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.25218119 |
| 69 | MP0002398_abnormal_bone_marrow | 1.25034257 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 1.23796597 |
| 71 | MP0005451_abnormal_body_composition | 1.22598396 |
| 72 | MP0003828_pulmonary_edema | 1.21950847 |
| 73 | MP0001348_abnormal_lacrimal_gland | 1.21678983 |
| 74 | MP0003091_abnormal_cell_migration | 1.19772777 |
| 75 | MP0001346_abnormal_lacrimal_gland | 1.15277342 |
| 76 | MP0000858_altered_metastatic_potential | 1.14668454 |
| 77 | MP0002009_preneoplasia | 1.11513817 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 1.08190952 |
| 79 | MP0002233_abnormal_nose_morphology | 1.07737535 |
| 80 | MP0010307_abnormal_tumor_latency | 1.07353820 |
| 81 | MP0010368_abnormal_lymphatic_system | 1.02617290 |
| 82 | MP0002429_abnormal_blood_cell | 1.01889262 |
| 83 | MP0008057_abnormal_DNA_replication | 0.99654401 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.98521425 |
| 85 | MP0003075_altered_response_to | 0.95201399 |
| 86 | MP0002638_abnormal_pupillary_reflex | 0.94250267 |
| 87 | MP0003634_abnormal_glial_cell | 0.94199085 |
| 88 | MP0000372_irregular_coat_pigmentation | 0.90976872 |
| 89 | MP0001879_abnormal_lymphatic_vessel | 0.87802536 |
| 90 | MP0005390_skeleton_phenotype | 0.87800924 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.87429155 |
| 92 | MP0005379_endocrine/exocrine_gland_phen | 0.86332189 |
| 93 | MP0003195_calcinosis | 0.86155111 |
| 94 | MP0008961_abnormal_basal_metabolism | 0.85251968 |
| 95 | MP0000689_abnormal_spleen_morphology | 0.84812536 |
| 96 | MP0005647_abnormal_sex_gland | 0.84337822 |
| 97 | MP0002177_abnormal_outer_ear | 0.82635526 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.82447706 |
| 99 | MP0003300_gastrointestinal_ulcer | 0.82245019 |
| 100 | MP0005408_hypopigmentation | 0.81876265 |
| 101 | MP0003646_muscle_fatigue | 0.81212219 |
| 102 | MP0005595_abnormal_vascular_smooth | 0.80549914 |
| 103 | MP0002092_abnormal_eye_morphology | 0.78890002 |
| 104 | MP0003329_amyloid_beta_deposits | 0.78623328 |
| 105 | MP0000747_muscle_weakness | 0.78179617 |
| 106 | MP0004270_analgesia | 0.78006455 |
| 107 | MP0010234_abnormal_vibrissa_follicle | 0.76117473 |
| 108 | MP0000604_amyloidosis | 0.75985439 |
| 109 | MP0002722_abnormal_immune_system | 0.75195196 |
| 110 | MP0005257_abnormal_intraocular_pressure | 0.74668499 |
| 111 | MP0005164_abnormal_response_to | 0.73096512 |
| 112 | MP0000343_altered_response_to | 0.73080786 |
| 113 | MP0005266_abnormal_metabolism | 0.72864179 |
| 114 | MP0001293_anophthalmia | 0.72259306 |
| 115 | MP0005197_abnormal_uvea_morphology | 0.72139428 |
| 116 | MP0004215_abnormal_myocardial_fiber | 0.70776659 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.70455628 |
| 118 | MP0005220_abnormal_exocrine_pancreas | 0.70395756 |
| 119 | MP0002095_abnormal_skin_pigmentation | 0.70285662 |
| 120 | MP0001440_abnormal_grooming_behavior | 0.69835049 |
| 121 | MP0010386_abnormal_urinary_bladder | 0.69660668 |
| 122 | MP0009333_abnormal_splenocyte_physiolog | 0.69458699 |
| 123 | MP0004782_abnormal_surfactant_physiolog | 0.69433545 |
| 124 | MP0000627_abnormal_mammary_gland | 0.69415157 |
| 125 | MP0003633_abnormal_nervous_system | 0.68012369 |
| 126 | MP0000249_abnormal_blood_vessel | 0.67862480 |
| 127 | MP0003943_abnormal_hepatobiliary_system | 0.66921433 |
| 128 | MP0009763_increased_sensitivity_to | 0.66032418 |
| 129 | MP0002168_other_aberrant_phenotype | 0.65815853 |
| 130 | MP0000955_abnormal_spinal_cord | 0.65647598 |
| 131 | MP0002972_abnormal_cardiac_muscle | 0.65586315 |
| 132 | MP0004808_abnormal_hematopoietic_stem | 0.64968770 |
| 133 | MP0001873_stomach_inflammation | 0.64601464 |
| 134 | MP0002332_abnormal_exercise_endurance | 0.61622526 |
| 135 | MP0005171_absent_coat_pigmentation | 0.61441923 |
| 136 | MP0001186_pigmentation_phenotype | 0.60027422 |
| 137 | MP0002933_joint_inflammation | 0.59749572 |
| 138 | MP0005166_decreased_susceptibility_to | 0.59589324 |
| 139 | MP0003045_fibrosis | 0.58823484 |
| 140 | MP0001851_eye_inflammation | 0.58769318 |
| 141 | MP0003795_abnormal_bone_structure | 0.56127980 |
| 142 | MP0000733_abnormal_muscle_development | 0.52014224 |
| 143 | MP0003191_abnormal_cellular_cholesterol | 0.50832889 |
| 144 | MP0001324_abnormal_eye_pigmentation | 0.50028777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 6.99611997 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.97918369 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.65982201 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.94081001 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 5.80956470 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.78841046 |
| 7 | Optic neuritis (HP:0100653) | 4.50137570 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.50137570 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.45439539 |
| 10 | Stomatitis (HP:0010280) | 4.39983839 |
| 11 | Vertebral arch anomaly (HP:0008438) | 4.34532157 |
| 12 | Gingivitis (HP:0000230) | 4.28733713 |
| 13 | Large earlobe (HP:0009748) | 4.15194372 |
| 14 | Orchitis (HP:0100796) | 4.12180303 |
| 15 | Recurrent skin infections (HP:0001581) | 4.07801966 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.99460317 |
| 17 | Autoimmune thrombocytopenia (HP:0001973) | 3.93815798 |
| 18 | Prostate neoplasm (HP:0100787) | 3.92996796 |
| 19 | Vasculitis (HP:0002633) | 3.71236829 |
| 20 | Increased IgM level (HP:0003496) | 3.60651748 |
| 21 | Recurrent viral infections (HP:0004429) | 3.60451017 |
| 22 | Myositis (HP:0100614) | 3.56830422 |
| 23 | Thick nail (HP:0001805) | 3.56731330 |
| 24 | Periodontitis (HP:0000704) | 3.54446807 |
| 25 | Obstructive lung disease (HP:0006536) | 3.44059885 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.44059885 |
| 27 | Pulmonary infiltrates (HP:0002113) | 3.42962622 |
| 28 | Hematochezia (HP:0002573) | 3.34287182 |
| 29 | Apathy (HP:0000741) | 3.28164631 |
| 30 | Fetal akinesia sequence (HP:0001989) | 3.28120375 |
| 31 | Abnormal pancreas size (HP:0012094) | 3.15709089 |
| 32 | Tented upper lip vermilion (HP:0010804) | 3.15701714 |
| 33 | Myocardial infarction (HP:0001658) | 2.93749279 |
| 34 | Papillary thyroid carcinoma (HP:0002895) | 2.92363612 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 2.91979311 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 2.88704732 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.88704732 |
| 38 | Tetraparesis (HP:0002273) | 2.87339907 |
| 39 | Leukocytosis (HP:0001974) | 2.84112573 |
| 40 | Diminished motivation (HP:0000745) | 2.83445492 |
| 41 | Neurofibrillary tangles (HP:0002185) | 2.81900823 |
| 42 | Arterial thrombosis (HP:0004420) | 2.81229711 |
| 43 | Tongue fasciculations (HP:0001308) | 2.78127021 |
| 44 | Cubitus valgus (HP:0002967) | 2.69794399 |
| 45 | Exocrine pancreatic insufficiency (HP:0001738) | 2.65476034 |
| 46 | Basal ganglia calcification (HP:0002135) | 2.64373134 |
| 47 | Gastrointestinal stroma tumor (HP:0100723) | 2.62309990 |
| 48 | Porencephaly (HP:0002132) | 2.59374236 |
| 49 | Premature loss of primary teeth (HP:0006323) | 2.59148255 |
| 50 | Abnormality of the right ventricle (HP:0001707) | 2.57504415 |
| 51 | Thoracolumbar scoliosis (HP:0002944) | 2.57366246 |
| 52 | Cellulitis (HP:0100658) | 2.53657409 |
| 53 | Abnormality of the nasal septum (HP:0000419) | 2.47997659 |
| 54 | Osteomyelitis (HP:0002754) | 2.42716600 |
| 55 | Recurrent pneumonia (HP:0006532) | 2.40954968 |
| 56 | Flattened epiphyses (HP:0003071) | 2.39981921 |
| 57 | Submucous cleft hard palate (HP:0000176) | 2.39770192 |
| 58 | Pulmonic stenosis (HP:0001642) | 2.39584394 |
| 59 | Gingival bleeding (HP:0000225) | 2.39542832 |
| 60 | Urticaria (HP:0001025) | 2.38403908 |
| 61 | Inappropriate behavior (HP:0000719) | 2.36852853 |
| 62 | Widely spaced teeth (HP:0000687) | 2.35468953 |
| 63 | Stomach cancer (HP:0012126) | 2.34552054 |
| 64 | Drooling (HP:0002307) | 2.34088731 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.33804732 |
| 66 | Retinal atrophy (HP:0001105) | 2.33344412 |
| 67 | Loss of speech (HP:0002371) | 2.32470570 |
| 68 | Anhidrosis (HP:0000970) | 2.27048858 |
| 69 | Increased cerebral lipofuscin (HP:0011813) | 2.25993950 |
| 70 | Muscle fibrillation (HP:0010546) | 2.25382811 |
| 71 | Abnormality of the fingertips (HP:0001211) | 2.24475221 |
| 72 | Meningitis (HP:0001287) | 2.24249546 |
| 73 | Excessive salivation (HP:0003781) | 2.23639774 |
| 74 | Cortical dysplasia (HP:0002539) | 2.23571206 |
| 75 | IgA deficiency (HP:0002720) | 2.22201009 |
| 76 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.21815891 |
| 77 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.20241947 |
| 78 | Bone pain (HP:0002653) | 2.20080615 |
| 79 | Axonal loss (HP:0003447) | 2.19026645 |
| 80 | Abnormality of salivation (HP:0100755) | 2.17839591 |
| 81 | Osteolytic defects of the hand bones (HP:0009699) | 2.17771611 |
| 82 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.17771611 |
| 83 | Muscle fiber inclusion bodies (HP:0100299) | 2.17530066 |
| 84 | Keratoconjunctivitis (HP:0001096) | 2.16882811 |
| 85 | Interstitial pulmonary disease (HP:0006530) | 2.16606623 |
| 86 | Pustule (HP:0200039) | 2.16108544 |
| 87 | Eosinophilia (HP:0001880) | 2.15532771 |
| 88 | Esophageal varix (HP:0002040) | 2.13236493 |
| 89 | Pulmonary artery stenosis (HP:0004415) | 2.12802901 |
| 90 | Alveolar cell carcinoma (HP:0006519) | 2.12003658 |
| 91 | Vacuolated lymphocytes (HP:0001922) | 2.11534503 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.11526429 |
| 93 | Esotropia (HP:0000565) | 2.10041925 |
| 94 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.08834358 |
| 95 | Blue irides (HP:0000635) | 2.08557702 |
| 96 | Xerostomia (HP:0000217) | 2.07482122 |
| 97 | Poor eye contact (HP:0000817) | 2.07012307 |
| 98 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.06773934 |
| 99 | Thoracic kyphosis (HP:0002942) | 2.06602170 |
| 100 | Barrel-shaped chest (HP:0001552) | 2.04471313 |
| 101 | Nemaline bodies (HP:0003798) | 2.03369189 |
| 102 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.02216361 |
| 103 | Frequent falls (HP:0002359) | 2.01059156 |
| 104 | Peritonitis (HP:0002586) | 1.99818488 |
| 105 | Hemoptysis (HP:0002105) | 1.99348762 |
| 106 | Subaortic stenosis (HP:0001682) | 1.98351078 |
| 107 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.98351078 |
| 108 | Colitis (HP:0002583) | 1.98311718 |
| 109 | Mutism (HP:0002300) | 1.98107031 |
| 110 | Tracheomalacia (HP:0002779) | 1.96500867 |
| 111 | Irregular vertebral endplates (HP:0003301) | 1.96204294 |
| 112 | Disinhibition (HP:0000734) | 1.95298201 |
| 113 | Systemic lupus erythematosus (HP:0002725) | 1.94668849 |
| 114 | Absent frontal sinuses (HP:0002688) | 1.93591466 |
| 115 | Recurrent lower respiratory tract infections (HP:0002783) | 1.93380340 |
| 116 | Albinism (HP:0001022) | 1.93009407 |
| 117 | Shawl scrotum (HP:0000049) | 1.89260634 |
| 118 | Progressive visual loss (HP:0000529) | 1.89032088 |
| 119 | Calf muscle hypertrophy (HP:0008981) | 1.88979117 |
| 120 | Bladder neoplasm (HP:0009725) | 1.87355123 |
| 121 | Bladder carcinoma (HP:0002862) | 1.87355123 |
| 122 | Restrictive lung disease (HP:0002091) | 1.87082949 |
| 123 | Chronic hepatic failure (HP:0100626) | 1.86207378 |
| 124 | Rimmed vacuoles (HP:0003805) | 1.86130380 |
| 125 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.83482714 |
| 126 | Thyroid carcinoma (HP:0002890) | 1.82851698 |
| 127 | Abnormality of the pericardium (HP:0001697) | 1.82815220 |
| 128 | Absent hand (HP:0004050) | 1.82272968 |
| 129 | Vertebral compression fractures (HP:0002953) | 1.82165591 |
| 130 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.80297779 |
| 131 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.78290341 |
| 132 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.77524362 |
| 133 | Arthralgia (HP:0002829) | 1.76168335 |
| 134 | Onycholysis (HP:0001806) | 1.76018431 |
| 135 | Cerebral inclusion bodies (HP:0100314) | 1.75929971 |
| 136 | Joint swelling (HP:0001386) | 1.75357685 |
| 137 | Pheochromocytoma (HP:0002666) | 1.75167994 |
| 138 | Abnormality of the prostate (HP:0008775) | 1.74645500 |
| 139 | Abnormality of glycolipid metabolism (HP:0010969) | 1.74500603 |
| 140 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.74500603 |
| 141 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.74500603 |
| 142 | Progressive sensorineural hearing impairment (HP:0000408) | 1.74130746 |
| 143 | Natal tooth (HP:0000695) | 1.74085410 |
| 144 | Portal hypertension (HP:0001409) | 1.74063221 |
| 145 | Absent speech (HP:0001344) | 1.73949838 |
| 146 | Abnormality of the hepatic vasculature (HP:0006707) | 1.72713973 |
| 147 | Recurrent sinusitis (HP:0011108) | 1.72555642 |
| 148 | Megalencephaly (HP:0001355) | 1.71712477 |
| 149 | Abnormality of eosinophils (HP:0001879) | 1.70759262 |
| 150 | Thyroiditis (HP:0100646) | 1.70040962 |
| 151 | Sepsis (HP:0100806) | 1.70013285 |
| 152 | Abnormality of the periventricular white matter (HP:0002518) | 1.69160765 |
| 153 | Fatigue (HP:0012378) | 1.68633967 |
| 154 | Truncal obesity (HP:0001956) | 1.68402279 |
| 155 | Granulocytopenia (HP:0001913) | 1.68246951 |
| 156 | Increased CSF protein (HP:0002922) | 1.68071796 |
| 157 | Protruding tongue (HP:0010808) | 1.67576670 |
| 158 | Acrocyanosis (HP:0001063) | 1.66574631 |
| 159 | Hypoplasia of the iris (HP:0007676) | 1.66557453 |
| 160 | Limited hip movement (HP:0008800) | 1.65191305 |
| 161 | Abnormality of the endocardium (HP:0004306) | 1.64372544 |
| 162 | Spastic tetraparesis (HP:0001285) | 1.64171114 |
| 163 | Round face (HP:0000311) | 1.64132812 |
| 164 | Asymmetric septal hypertrophy (HP:0001670) | 1.63791121 |
| 165 | Autoimmune hemolytic anemia (HP:0001890) | 1.63469717 |
| 166 | Shoulder girdle muscle weakness (HP:0003547) | 1.62728114 |
| 167 | Abnormality of the pleura (HP:0002103) | 1.62702904 |
| 168 | Glomerulonephritis (HP:0000099) | 1.62661446 |
| 169 | Myoglobinuria (HP:0002913) | 1.61804855 |
| 170 | Persistence of primary teeth (HP:0006335) | 1.61803466 |
| 171 | Amyloidosis (HP:0011034) | 1.61749833 |
| 172 | Action tremor (HP:0002345) | 1.61419090 |
| 173 | Renal tubular acidosis (HP:0001947) | 1.59265251 |
| 174 | Abnormality of the gastric mucosa (HP:0004295) | 1.57990338 |
| 175 | Febrile seizures (HP:0002373) | 1.57964442 |
| 176 | Cerebral hemorrhage (HP:0001342) | 1.57705306 |
| 177 | Acute myeloid leukemia (HP:0004808) | 1.55671125 |
| 178 | Personality changes (HP:0000751) | 1.55670860 |
| 179 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.54771351 |
| 180 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.54771351 |
| 181 | Leiomyosarcoma (HP:0100243) | 1.52842397 |
| 182 | Uterine leiomyosarcoma (HP:0002891) | 1.52842397 |
| 183 | Short 4th metacarpal (HP:0010044) | 1.52733512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 8.93515610 |
| 2 | MAP3K14 | 5.88181948 |
| 3 | TAOK2 | 5.21424808 |
| 4 | RIPK4 | 4.33731810 |
| 5 | IKBKB | 3.47077332 |
| 6 | IRAK4 | 3.38779312 |
| 7 | TBK1 | 3.27068631 |
| 8 | CHUK | 3.10467595 |
| 9 | IRAK3 | 3.09173200 |
| 10 | TYK2 | 3.00215773 |
| 11 | IKBKE | 2.96309284 |
| 12 | JAK3 | 2.72216911 |
| 13 | MAP3K13 | 2.62103041 |
| 14 | BMPR2 | 2.52026360 |
| 15 | SIK3 | 2.23489549 |
| 16 | JAK1 | 2.17549315 |
| 17 | LMTK2 | 2.14345520 |
| 18 | DDR2 | 2.02778511 |
| 19 | PBK | 1.96743245 |
| 20 | STK24 | 1.86273966 |
| 21 | TAOK3 | 1.78420283 |
| 22 | ERBB3 | 1.67830564 |
| 23 | EIF2AK3 | 1.58416649 |
| 24 | RPS6KA4 | 1.56032971 |
| 25 | MARK1 | 1.51702155 |
| 26 | NEK9 | 1.44954846 |
| 27 | TXK | 1.44276726 |
| 28 | CDK19 | 1.43179624 |
| 29 | OBSCN | 1.42588051 |
| 30 | FGFR3 | 1.35113290 |
| 31 | BLK | 1.26254342 |
| 32 | PDGFRA | 1.26251095 |
| 33 | INSRR | 1.25042001 |
| 34 | BCR | 1.24654811 |
| 35 | KIT | 1.19350341 |
| 36 | EIF2AK2 | 1.17109065 |
| 37 | EEF2K | 1.11535334 |
| 38 | TGFBR1 | 1.10410843 |
| 39 | CDK12 | 1.09662690 |
| 40 | ZAK | 1.07227938 |
| 41 | IRAK1 | 1.06355653 |
| 42 | YES1 | 1.04961938 |
| 43 | PIM1 | 1.02216843 |
| 44 | IRAK2 | 1.00968568 |
| 45 | LATS2 | 0.99803359 |
| 46 | MKNK1 | 0.96232311 |
| 47 | MAP4K1 | 0.94706940 |
| 48 | MKNK2 | 0.93797216 |
| 49 | PKN1 | 0.93238080 |
| 50 | TRPM7 | 0.91728030 |
| 51 | MAP3K5 | 0.91727736 |
| 52 | JAK2 | 0.90261412 |
| 53 | CDK8 | 0.89504777 |
| 54 | MAP3K4 | 0.89011439 |
| 55 | BMPR1B | 0.88978227 |
| 56 | NUAK1 | 0.88417024 |
| 57 | SGK2 | 0.87714873 |
| 58 | PHKG1 | 0.87363487 |
| 59 | PHKG2 | 0.87363487 |
| 60 | STK38L | 0.87152025 |
| 61 | EPHB2 | 0.85660733 |
| 62 | STK3 | 0.83646471 |
| 63 | CAMK1G | 0.83494738 |
| 64 | MARK3 | 0.83376662 |
| 65 | GRK7 | 0.82336581 |
| 66 | DMPK | 0.81735934 |
| 67 | BMX | 0.81145743 |
| 68 | AKT3 | 0.80447358 |
| 69 | CCNB1 | 0.80198990 |
| 70 | TNIK | 0.79656115 |
| 71 | PLK2 | 0.77155187 |
| 72 | SYK | 0.75934525 |
| 73 | EPHA3 | 0.75430377 |
| 74 | STK4 | 0.75330966 |
| 75 | FGFR4 | 0.74646026 |
| 76 | PIM2 | 0.74632117 |
| 77 | CAMK1D | 0.73551958 |
| 78 | ERBB4 | 0.71457919 |
| 79 | KSR1 | 0.70924930 |
| 80 | TYRO3 | 0.70901300 |
| 81 | CSK | 0.70709981 |
| 82 | HCK | 0.70438187 |
| 83 | CSF1R | 0.70227020 |
| 84 | LCK | 0.69336640 |
| 85 | PNCK | 0.68644177 |
| 86 | MOS | 0.68438378 |
| 87 | PTK6 | 0.66907989 |
| 88 | SGK3 | 0.63893469 |
| 89 | PRKCD | 0.62956749 |
| 90 | MAPK7 | 0.62276878 |
| 91 | EGFR | 0.61792978 |
| 92 | SGK1 | 0.60190621 |
| 93 | MELK | 0.59435531 |
| 94 | LYN | 0.59369267 |
| 95 | CASK | 0.59338268 |
| 96 | MAP3K10 | 0.58061210 |
| 97 | TTN | 0.57797854 |
| 98 | PRKCH | 0.55120190 |
| 99 | PRKAA1 | 0.53589619 |
| 100 | ZAP70 | 0.53575685 |
| 101 | MAP2K7 | 0.53126649 |
| 102 | ABL2 | 0.52616631 |
| 103 | MAPK11 | 0.51943666 |
| 104 | MST1R | 0.51246416 |
| 105 | FRK | 0.50204482 |
| 106 | ABL1 | 0.49883741 |
| 107 | MAPK12 | 0.49864223 |
| 108 | SIK2 | 0.49719818 |
| 109 | BTK | 0.49456995 |
| 110 | FGR | 0.48748285 |
| 111 | ADRBK2 | 0.48566819 |
| 112 | CDC42BPA | 0.45748332 |
| 113 | PRKAA2 | 0.44997058 |
| 114 | PRKCQ | 0.44505170 |
| 115 | TEC | 0.44421767 |
| 116 | PDGFRB | 0.44139940 |
| 117 | EPHB1 | 0.43927524 |
| 118 | PRKCE | 0.42927934 |
| 119 | MAPKAPK2 | 0.42504198 |
| 120 | GSK3A | 0.42215754 |
| 121 | MAPKAPK3 | 0.42064105 |
| 122 | PRKCZ | 0.39618619 |
| 123 | MAP3K9 | 0.38675527 |
| 124 | NEK6 | 0.38327530 |
| 125 | MAPK4 | 0.35154104 |
| 126 | MATK | 0.33250193 |
| 127 | SGK494 | 0.33097579 |
| 128 | SGK223 | 0.33097579 |
| 129 | HIPK2 | 0.32984379 |
| 130 | MAP3K6 | 0.32676115 |
| 131 | MAP4K2 | 0.32301473 |
| 132 | MAP3K7 | 0.31941969 |
| 133 | AKT1 | 0.30426732 |
| 134 | MAPKAPK5 | 0.30341074 |
| 135 | CDK9 | 0.29028893 |
| 136 | ACVR1B | 0.28352607 |
| 137 | OXSR1 | 0.27928305 |
| 138 | RPS6KA6 | 0.27796354 |
| 139 | DAPK2 | 0.26819793 |
| 140 | TAOK1 | 0.26804582 |
| 141 | RPS6KA5 | 0.26706887 |
| 142 | RPS6KA1 | 0.26108718 |
| 143 | CSNK1A1L | 0.25935757 |
| 144 | STK11 | 0.25365638 |
| 145 | RPS6KA2 | 0.24441765 |
| 146 | BRD4 | 0.22816315 |
| 147 | WNK1 | 0.22522918 |
| 148 | CDK6 | 0.21761692 |
| 149 | ERN1 | 0.19025894 |
| 150 | LATS1 | 0.18602135 |
| 151 | IGF1R | 0.18181217 |
| 152 | TGFBR2 | 0.17681852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.16914929 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.16456076 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.12896644 |
| 4 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 3.05218794 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.71178714 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.67603050 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.56368967 |
| 8 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.46944243 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.31096648 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29615528 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.12053229 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.11983783 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.11664975 |
| 14 | Malaria_Homo sapiens_hsa05144 | 2.05133363 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.04282546 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.97607972 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.97390899 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.89586798 |
| 19 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.88196688 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.82043066 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75235224 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.72357764 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64089844 |
| 24 | Apoptosis_Homo sapiens_hsa04210 | 1.57394481 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.53944272 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.50362334 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48737719 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43393597 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.41977106 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.40775481 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38609363 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33891600 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31089218 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.28080936 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.27984171 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21206317 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.20527164 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15297112 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14601626 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.13125732 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.10418020 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.08742939 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.05748188 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.03220644 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99476299 |
| 46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99256520 |
| 47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98840077 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93772214 |
| 49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93708491 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92529336 |
| 51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91604393 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89891695 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87467449 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 0.87439291 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85653313 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83780375 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81231102 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.81072652 |
| 59 | Focal adhesion_Homo sapiens_hsa04510 | 0.80834384 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80024083 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79798803 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79160725 |
| 63 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78951108 |
| 64 | Bile secretion_Homo sapiens_hsa04976 | 0.78051088 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70608372 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69167541 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68292684 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67506561 |
| 69 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66064989 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66061306 |
| 71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64613683 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64317491 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63203456 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62860526 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.62667574 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62639148 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60253122 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58213353 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57413672 |
| 80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55415590 |
| 81 | Melanoma_Homo sapiens_hsa05218 | 0.55066522 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53945628 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.52965004 |
| 84 | Adherens junction_Homo sapiens_hsa04520 | 0.52954471 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52002936 |
| 86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51660122 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51655076 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50848315 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50134157 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48612242 |
| 91 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48574508 |
| 92 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.48429256 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48220404 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.47072779 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45524697 |
| 96 | Pathways in cancer_Homo sapiens_hsa05200 | 0.45404547 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43887238 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42304191 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40396441 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40118915 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39823656 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39455790 |
| 103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35473204 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34485948 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.34420978 |
| 106 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.33797543 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.33608316 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32882016 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32492988 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31916171 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31897077 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31439976 |
| 113 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.31343160 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30140192 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28529992 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28138289 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27833770 |
| 118 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.27515502 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26533485 |
| 120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26523007 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25943704 |
| 122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25166900 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25146541 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24893347 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23928584 |

